Urology

Category: Nephrology (Kidney), HIC#13684
Title:
A Phase 2, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled study to Determine Growth Hormone Secretagogue MK-0677's effect on Lean Body Mass in Chronic Kidney Disease Subjects with Stage 4 and Stage 5 Kidney Disease (WKB014)
Contact:Sharon (Lisa) Johnson
Phone:(434)982-3198
E-mail:sfj8n@virginia.edu

Do You Have Stage 4 or Stage 5 Kidney Disease?

If so, you may qualify for a clinical research study being conducted at the University of Virginia's Nephrology Clinical Research Center.

The Division of Nephrology is looking for men and women who have stage 4 or stage 5 disease to participate in a research study using an investigational medication. This investigational medication has been shown to increase growth hormone in healthy and elderly people and is now being researched to see if it can increase the growth hormone levels in people who have kidney disease.

Did you know Growth Hormone:
Is needed for growth?
Peaks in adolescence?
Levels decrease with age?
Increases muscle mass?
Increases sense of well being?
Increases libido (sexual desire)?
Increases energy and strength?
Increases appetite?
Decreases body fat?

Qualified study participants will receive:

Study Related Physical Exams
Laboratory Testing
Compensation for time and travel of up to $375.00

For more information and to see if you qualify, please call the Nephrology Clinical Research Center at 982-3198.

IRB-HSR #13684
Principal Investigator: W. Kline Bolton, MD
Primary Investigator: Bolton W. Kline,
Department: Internal Medicine
Division: Nephrology 		Accepts adult enrollment :YES
Accepts minor enrollment :NO